Arkema to Boost Production of Pebax TPEs
The company will increase it global manufacturing capacity for these polyether-block-amide (PEBA) elastomers by 25%.
Through an investment at its Serquigny, France plant, Arkema plans to increase its global manufacturing capacity for Pebax thermoplastic polyether-block-amide TPEs by approximately 25%, to meet increased market demand from the sports and consumer goods sectors. This investment will notably enable increased production of the biocircular Pebax Rnew which are based on the company’s nylon 11 chemistry, and traditional Pebax ranges.
This new capacity, due on stream in mid-2023, will produce a variety of highly specialized grades to meet growing demand in numerous demanding applications thanks to the lightweight, flexibility and excellent energy return of these materials, says Arkema. These properties are particularly appreciated in sports equipment, such as soles for running shoes, ski boots or technical textile, in consumer goods such as smartphones and flexible screens, as well as in other markets such as medical equipment.
Derived from renewable castor seeds, Pebax Rnew biocircular TPEs reportedly have a carbon footprint that is up to 50% lower and can be fully recycled compared to other elastomers on the market.
Related Content
-
Medical Grade TPEs for Biopharmaceutical Tubing
Teknor Apex expands its Medalist TPE portfolio.
-
Printable Thermoset Polyurethane
Chromatic 3D Materials launched ChromaMotive D65, designed for additive manufacturing.
-
ICIS Launches: Ask ICIS Generative AI Commodities Assistant
Said to be the first of its kind, this AI assistant will enhance access to ICIS’ intelligence and insights for the energy and chemical markets.